A new research report by Transparency Market Research features the changing trends and future growth prospects of the global brain imaging, biomarkers and neuroinformatics market. As per the report, imaging has now become an essential tool for research and clinical activities. Brain imaging assists physicians and researchers to find areas of the brain that are affected by neurological disorders. Brain imaging is also being increasingly used to formulate new strategies to treat various brain disorders. Non-invasive brain imaging techniques help physicians and researchers to find out neural networks in the cognitive pathway.
The report, titled “Brain Imaging, Biomarkers and NeuroInformatics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,” defines brain imaging, biomarkers, and neuroinformatics. Biomarkers identify the progress of a disease and evaluate the most effective therapy for the disease. Neuroinformatics consists software systems and multidimensional databases that store, analyze, and manage information from genetic to behavioral level. Biomarkers play a key role in neuroscience to identify the number of abnormalities and neurological disorders.
The rising number of aging people is the root cause of the rising number of neurological disorders. Thus, this is also expected to propel the global brain imaging, biomarkers and neuroinformatics market throughout the forecast period. Aged people are prone to various neurological disorders, brain disorders, and cardiovascular diseases. According to the World Health Organization, approximately 14.1% of the global population are likely to suffer from various neurological disorders by 2020. This is expected to create growth opportunities for key players operating in the global brain imaging, biomarkers and neuroinformatics market.
View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3851
Some of the companies operating in the global brain imaging, biomarkers and neuroinformatics market are Abbot Diagnostics, Advanced Brain Monitoring, Johnson & Johnson, NeuroVigil, Philips Healthcare, Aspect Medical (Covidien), Natus Medical, Zynex, Brain Resource, Electrical Geodesics, GE Healthcare, Bio-Rad, Quest Diagnostics, NeuroVista, and BrainScope. Many players are concentrating on upgrading neuroimaging techniques such as computed tomography, nuclear medicine imaging, magnetoencephalography (EEG), and electroencephalography.
The global brain imaging, biomarkers and neuroinformatics market is regionally divided into Asia Pacific, North America, Europe, and Rest of the World. At present, the global brain imaging, biomarkers and neuroinformatics market is dominated by North America, followed by Europe. However, Asia Pacific is predicted to be the most promising market for brain imaging, biomarkers and neuroinformatics in the coming future. It is found that, globally every year, around 100 million people suffer from nervous system or brain disorders such as Parkinson’s disease, Alzheimer’s disease, schizophrenia, and sleep disorders. This is predicted to propel the demand for brain imaging, biomarkers and neuroinformatics.
Transparency Market Research
90 State Street,
NY - 12207
USA - Canada Toll Free 866-552-3453
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.